These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 18245396

  • 21. Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury.
    Zareba G, Cernichiari E, Hojo R, Nitt SM, Weiss B, Mumtaz MM, Jones DE, Clarkson TW.
    J Appl Toxicol; 2007; 27(5):511-8. PubMed ID: 17582588
    [Abstract] [Full Text] [Related]

  • 22. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.
    Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T.
    Environ Health Perspect; 2005 Aug; 113(8):1015-21. PubMed ID: 16079072
    [Abstract] [Full Text] [Related]

  • 23. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.
    Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
    [Abstract] [Full Text] [Related]

  • 24. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Vaccine Safety Datalink Team.
    N Engl J Med; 2007 Sep 27; 357(13):1281-92. PubMed ID: 17898097
    [Abstract] [Full Text] [Related]

  • 25. Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury.
    Dórea JG, Farina M, Rocha JB.
    J Appl Toxicol; 2013 Aug 27; 33(8):700-11. PubMed ID: 23401210
    [Abstract] [Full Text] [Related]

  • 26. Changes in children hair-Hg concentrations during the first 5 years: maternal, environmental and iatrogenic modifying factors.
    Marques RC, Dórea JG, Bastos WR, Malm O.
    Regul Toxicol Pharmacol; 2007 Oct 27; 49(1):17-24. PubMed ID: 17566620
    [Abstract] [Full Text] [Related]

  • 27. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice.
    Berman RF, Pessah IN, Mouton PR, Mav D, Harry J.
    Toxicol Sci; 2008 Feb 27; 101(2):294-309. PubMed ID: 17977901
    [Abstract] [Full Text] [Related]

  • 28. Update: expanded availability of thimerosal preservative-free hepatitis B vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Jul 21; 49(28):642, 651. PubMed ID: 10926308
    [Abstract] [Full Text] [Related]

  • 29. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chiarotti F, Salmaso S.
    Pediatrics; 2009 Feb 21; 123(2):475-82. PubMed ID: 19171612
    [Abstract] [Full Text] [Related]

  • 30. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ, McIntyre PB.
    Expert Opin Drug Saf; 2006 Jan 21; 5(1):17-29. PubMed ID: 16370953
    [Abstract] [Full Text] [Related]

  • 31. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG, Marques RC.
    Toxicol Sci; 2008 Jun 21; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased ethyl mercury load in protein a immunoadsorption.
    Marn-Pernat A, Buturović-Ponikvar J, Logar M, Horvat M, Ponikvar R.
    Ther Apher Dial; 2005 Jun 21; 9(3):254-7. PubMed ID: 15967001
    [Abstract] [Full Text] [Related]

  • 34. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
    Geier DA, Geier MR.
    Neuro Endocrinol Lett; 2006 Aug 21; 27(4):401-13. PubMed ID: 16807526
    [Abstract] [Full Text] [Related]

  • 35. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months.
    Dórea JG, Marques RC.
    J Expo Sci Environ Epidemiol; 2010 Nov 21; 20(7):598-601. PubMed ID: 20010978
    [Abstract] [Full Text] [Related]

  • 36. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
    Marques RC, Dórea JG, Bernardi JV.
    Acta Paediatr; 2010 Jun 21; 99(6):934-9. PubMed ID: 20003103
    [Abstract] [Full Text] [Related]

  • 37. Automated speciation of mercury in the hair of breastfed infants exposed to ethylmercury from thimerosal-containing vaccines.
    Dórea JG, Wimer W, Marques RC, Shade C.
    Biol Trace Elem Res; 2011 Jun 21; 140(3):262-71. PubMed ID: 20419397
    [Abstract] [Full Text] [Related]

  • 38. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA, Geier MR.
    Med Sci Monit; 2005 Apr 21; 11(4):CR160-70. PubMed ID: 15795695
    [Abstract] [Full Text] [Related]

  • 39. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
    Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.
    Acta Paediatr; 2007 Jun 21; 96(6):864-8. PubMed ID: 17465985
    [Abstract] [Full Text] [Related]

  • 40. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET, Fiore AE, Strine TW, Barker LE.
    JAMA; 2004 May 19; 291(19):2351-8. PubMed ID: 15150207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.